Showing results (161-170 of 336) with videos related to

Sort By:
Pageof 34
Nephron|January 1, 1991
The role of membrane contact in hemodialysis-induced granulocyte activationG Kolb, C Nolting, I Eckle, et al.
Nephron|January 1, 1993
Granulocyte-monocyte colony-stimulating factor levels during hemodialysis-induced leukopeniaG Kolb, M Klausmann, I Eckle, et al.
Chirurgie (Heidelberg, Germany)|September 9, 2022
[After inconspicuous elective laparoscopic cholecystectomy patients can be discharged without control of laboratory parameters]L Fischer, K Watrinet, G Kolb, et al.
Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2006
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 updateC Bokemeyer, M S Aapro, A Courdi, et al.
Der Urologe. Ausg. A|October 31, 2018
[Positron emission tomography in germ cell tumors in men : Possibilities and limitations]P Schriefer, M Hartmann, K Oechsle, et al.
Annals of Hematology|June 1, 1996
Acquired C 1-inhibitor deficiency with angioedema due to pleomorphic immunocytoma in a patient with three malignant tumors: long-term follow-up data and presentation of an additional caseW Bohle, U Rüther, C Bokemeyer, et al.
Der Urologe. Ausg. A|March 1, 1995
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder]M A Kuczyk, J Serth, C Bokemeyer, et al.
Pageof 34